Get startedLog in
    Picture of Alligator Bioscience AB logo

    ATORX — Alligator Bioscience AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Alligator Bioscience, Aptevo Therapeutics Announce Positive Interim Data From Dose Escalation Phase Of Their Phase 1 Trial

    Picture of Alligator Bioscience AB logoAlligator Bioscience AB
    16/09/2024 13:12
    Sept 16 (Reuters) - Alligator Bioscience AB  ATORX.ST 
    * CO AND APTEVO THERAPEUTICS TODAY ANNOUNCED POSITIVE
INTERIM DATA
FROM DOSE ESCALATION PHASE OF THEIR PHASE 1 TRIAL EVALUATING
ALG.APV-527 FOR TREATMENT OF SOLID TUMORS LIKELY TO EXPRESS
TUMOR ANTIGEN 5T4

Source text for Eikon:  ID:nMFN46GfS4 
Further company coverage:  ATORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

    Recent news on Alligator Bioscience AB

    See all news